Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Search
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
Advances in vectored vaccines for poultry
Click here to learn how vaccine design technologies have made huge advances in recent years to overcome challenges that conventional vaccines do not meet.
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Coronavirus in pets and humans: learn the differences
Coronavirus in pets and humans: learn the differences. To date, there is no evidence that dogs and cats can be infected or transmit COVID-19.
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Saving Stroke Patients around the world
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Click here to learn about the Angels Initiative.
COVID-19 Pandemic support in Vietnam
Find out how Boehringer Ingelheim Vietnam is joining hands with the government and hospitals. Click here to find out and learn more information.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
COVID-19 Volunteering in Canada
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India. Click here to find out and learn more.
Xochimilco
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Xochimilco site.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks are in the news.
Science against COVID-19 fake news and misinformation
As there is no evidence that animals can transmit COVID-19, the livestock community highlights information to join the battle against false claims.
Introducing Karl and Klara Kidney
Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways. Click here to find out more.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
3 scopes for sustainability Saint Vulbas France
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
How pets made the pandemic bearable?
Lockdown wasn’t easy but having us work from home was certainly delightful for our pets. Learn some insights from the APPA COVID-19 Pulse Study.
Our Purpose
Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose.